Mirvetuximab (M9346A) is a monoclonal antibody targeting FOLR1 (folate receptor 1), specifically designed to bind to folate receptor alpha (FR??). This antibody serves as the crucial component of the antibody-drug conjugate (ADC) Mirvetuximab soravtansine, which is utilized in the investigation of ovarian and other FR??-positive cancers. Mirvetuximab soravtansine's mechanism focuses on delivering cytotoxic agents directly to cancer cells expressing FR??, thereby enhancing therapeutic efficacy while minimizing off-target effects. This product is essential for research aimed at developing targeted therapies for FR??-expressing tumors.
Mirvetuximab (M9346A) is a monoclonal antibody targeting FOLR1 (folate receptor 1), specifically designed to bind to folate receptor alpha (FR??). This antibody serves as the crucial component of the antibody-drug conjugate (ADC) Mirvetuximab soravtansine, which is utilized in the investigation of ovarian and other FR??-positive cancers. Mirvetuximab soravtansine's mechanism focuses on delivering cytotoxic agents directly to cancer cells expressing FR??, thereby enhancing therapeutic efficacy while minimizing off-target effects. This product is essential for research aimed at developing targeted therapies for FR??-expressing tumors.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
